These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 2281118)

  • 21. Interleukin-1 stimulates release of insulin-like growth factor-I from neonatal mouse calvaria by a prostaglandin synthesis-dependent mechanism.
    Linkhart TA; MacCharles DC
    Endocrinology; 1992 Nov; 131(5):2297-305. PubMed ID: 1425428
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effects of TGF-beta on bone.
    Mundy GR
    Ciba Found Symp; 1991; 157():137-43; discussion 143-51. PubMed ID: 2070682
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Prostaglandins in bone and cartilage metabolism].
    Karbowski A; Matthiass HH
    Z Orthop Ihre Grenzgeb; 1990; 128(2):115-22. PubMed ID: 2140640
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bone fragility: failure of periosteal apposition to compensate for increased endocortical resorption in postmenopausal women.
    Szulc P; Seeman E; Duboeuf F; Sornay-Rendu E; Delmas PD
    J Bone Miner Res; 2006 Dec; 21(12):1856-63. PubMed ID: 17002580
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biological aspects of altered bone remodeling in multiple myeloma and possibilities of pharmacological intervention.
    Kupisiewicz K
    Dan Med Bull; 2011 May; 58(5):B4277. PubMed ID: 21535989
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of prostaglandins on regional remodeling changes during tibial healing in beagles: a histomorphometric study.
    Shih MS; Norridin RW
    Calcif Tissue Int; 1986 Sep; 39(3):191-7. PubMed ID: 3093031
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel, non-prostanoid EP2 receptor-selective prostaglandin E2 agonist stimulates local bone formation and enhances fracture healing.
    Li M; Ke HZ; Qi H; Healy DR; Li Y; Crawford DT; Paralkar VM; Owen TA; Cameron KO; Lefker BA; Brown TA; Thompson DD
    J Bone Miner Res; 2003 Nov; 18(11):2033-42. PubMed ID: 14606517
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The roles of prostanoids, leukotrienes, and platelet-activating factor in bone metabolism and disease.
    Hikiji H; Takato T; Shimizu T; Ishii S
    Prog Lipid Res; 2008 Mar; 47(2):107-26. PubMed ID: 18187046
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bone resorption and prostaglandin production by mouse calvaria in vitro: response to exogenous prostaglandins and their precursor fatty acids.
    Katz JM; Wilson T; Skinner SJ; Gray DH
    Prostaglandins; 1981 Oct; 22(4):537-51. PubMed ID: 6798638
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bone cell interactions and regulation by inflammatory mediators.
    Oates TW; Cochran DL
    Curr Opin Periodontol; 1996; 3():34-44. PubMed ID: 8624568
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stimulation of bone resorption by various prostaglandins in organ culture.
    Dietrich JW; Goodson JM; Raisz LG
    Prostaglandins; 1975 Aug; 10(2):231-40. PubMed ID: 1178904
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bone resorption and humoral hypercalcemia of malignancy: stimulation of bone resorption in vitro by tumor extracts is inhibited by prostaglandin synthesis inhibitors.
    Minkin C; Fredericks RS; Pokress S; Rude RK; Sharp CF; Tong M; Singer FR
    J Clin Endocrinol Metab; 1981 Nov; 53(5):941-7. PubMed ID: 6793615
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Suppression of prostaglandin synthesis with NS-398 has different effects on endocortical and periosteal bone formation induced by mechanical loading.
    Li J; Burr DB; Turner CH
    Calcif Tissue Int; 2002 Apr; 70(4):320-9. PubMed ID: 12004337
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The cytokines that maintain living bone].
    Riancho JA; Zarrabeitia MT; González Macías J
    Med Clin (Barc); 1992 Jun; 99(3):110-5. PubMed ID: 1630198
    [No Abstract]   [Full Text] [Related]  

  • 35. Effect of cyclosporin A on bone mineral metabolism in experimental diabetes mellitus in the rat.
    Epstein S; Takizawa M; Stein B; Katz IA; Joffe II; Romero DF; Liang XG; Li M; Ke HZ; Jee WS
    J Bone Miner Res; 1994 Apr; 9(4):557-66. PubMed ID: 8030444
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rolipram, a phosphodiesterase 4 inhibitor, prevented cancellous and cortical bone loss by inhibiting endosteal bone resorption and maintaining the elevated periosteal bone formation in adult ovariectomized rats.
    Yao W; Tian XY; Chen J; Setterberg RB; Lundy MW; Chmielzwski P; Froman CA; Jee WS
    J Musculoskelet Neuronal Interact; 2007; 7(2):119-30. PubMed ID: 17627081
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New clues into the etiology of osteoporosis: the effects of prostaglandins (E2 and F2 alpha) on bone.
    Golde B
    Med Hypotheses; 1992 Jun; 38(2):125-31. PubMed ID: 1326711
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gene therapy methods in bone and joint disorders. Evaluation of the adeno-associated virus vector in experimental models of articular cartilage disorders, periprosthetic osteolysis and bone healing.
    Ulrich-Vinther M
    Acta Orthop Suppl; 2007 Apr; 78(325):1-64. PubMed ID: 17427340
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PGE2 stimulates both resorption and formation of bone in vitro: differential responses of the periosteum and the endosteum in fetal rat long bone cultures.
    Nefussi JR; Baron R
    Anat Rec; 1985 Jan; 211(1):9-16. PubMed ID: 3985383
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A histochemical study of bone remodeling during experimental apical periodontitis in rats.
    Anan H; Akamine A; Hara Y; Maeda K; Hashiguchi I; Aono M
    J Endod; 1991 Jul; 17(7):332-7. PubMed ID: 1723421
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.